annual CAPEX:
$246.50M+$16.10M(+6.99%)Summary
- As of today (May 29, 2025), UTHR annual capital expenditures is $246.50 million, with the most recent change of +$16.10 million (+6.99%) on December 31, 2024.
- During the last 3 years, UTHR annual CAPEX has risen by +$125.70 million (+104.06%).
- UTHR annual CAPEX is now at all-time high.
Performance
UTHR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$74.90M-$11.80M(-13.61%)Summary
- As of today (May 29, 2025), UTHR quarterly capital expenditures is $74.90 million, with the most recent change of -$11.80 million (-13.61%) on March 31, 2025.
- Over the past year, UTHR quarterly CAPEX has increased by +$36.70 million (+96.07%).
- UTHR quarterly CAPEX is now -13.61% below its all-time high of $86.70 million, reached on December 31, 2024.
Performance
UTHR quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$283.20M+$36.70M(+14.89%)Summary
- As of today (May 29, 2025), UTHR TTM capital expenditures is $283.20 million, with the most recent change of +$36.70 million (+14.89%) on March 31, 2025.
- Over the past year, UTHR TTM CAPEX has increased by +$55.90 million (+24.59%).
- UTHR TTM CAPEX is now at all-time high.
Performance
UTHR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
UTHR CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +7.0% | +96.1% | +24.6% |
3 y3 years | +104.1% | +454.8% | +128.9% |
5 y5 years | +194.5% | +476.1% | +295.5% |
UTHR CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +104.1% | -13.6% | +454.8% | at high | +128.9% |
5 y | 5-year | at high | +315.7% | -13.6% | +606.6% | at high | +414.9% |
alltime | all time | at high | >+9999.0% | -13.6% | >+9999.0% | at high | >+9999.0% |
UTHR CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $74.90M(-13.6%) | $283.20M(+14.9%) |
Dec 2024 | $246.50M(+7.0%) | $86.70M(+13.3%) | $246.50M(+3.4%) |
Sep 2024 | - | $76.50M(+69.6%) | $238.50M(+4.7%) |
Jun 2024 | - | $45.10M(+18.1%) | $227.70M(+0.2%) |
Mar 2024 | - | $38.20M(-51.5%) | $227.30M(-1.3%) |
Dec 2023 | $230.40M(+66.0%) | $78.70M(+19.8%) | $230.40M(+20.5%) |
Sep 2023 | - | $65.70M(+47.0%) | $191.20M(-1.6%) |
Jun 2023 | - | $44.70M(+8.2%) | $194.30M(+16.6%) |
Mar 2023 | - | $41.30M(+4.6%) | $166.60M(+20.0%) |
Dec 2022 | $138.80M(+14.9%) | $39.50M(-42.6%) | $138.80M(-18.3%) |
Sep 2022 | - | $68.80M(+304.7%) | $169.90M(+36.6%) |
Jun 2022 | - | $17.00M(+25.9%) | $124.40M(+0.6%) |
Mar 2022 | - | $13.50M(-80.9%) | $123.70M(+2.4%) |
Dec 2021 | $120.80M(+103.7%) | $70.60M(+203.0%) | $120.80M(+93.3%) |
Sep 2021 | - | $23.30M(+42.9%) | $62.50M(+13.6%) |
Jun 2021 | - | $16.30M(+53.8%) | $55.00M(-3.3%) |
Mar 2021 | - | $10.60M(-13.8%) | $56.90M(-4.0%) |
Dec 2020 | $59.30M(-29.2%) | $12.30M(-22.2%) | $59.30M(-17.3%) |
Sep 2020 | - | $15.80M(-13.2%) | $71.70M(+3.2%) |
Jun 2020 | - | $18.20M(+40.0%) | $69.50M(-2.9%) |
Mar 2020 | - | $13.00M(-47.4%) | $71.60M(-14.5%) |
Dec 2019 | $83.70M(-54.6%) | $24.70M(+81.6%) | $83.70M(-24.5%) |
Sep 2019 | - | $13.60M(-33.0%) | $110.80M(-20.1%) |
Jun 2019 | - | $20.30M(-19.1%) | $138.70M(-19.3%) |
Mar 2019 | - | $25.10M(-51.5%) | $171.90M(-6.8%) |
Dec 2018 | $184.40M(+113.7%) | $51.80M(+24.8%) | $184.40M(+15.0%) |
Sep 2018 | - | $41.50M(-22.4%) | $160.40M(+13.8%) |
Jun 2018 | - | $53.50M(+42.3%) | $140.90M(+30.1%) |
Mar 2018 | - | $37.60M(+35.3%) | $108.30M(+25.5%) |
Dec 2017 | $86.30M(+127.1%) | $27.80M(+26.4%) | $86.30M(+26.9%) |
Sep 2017 | - | $22.00M(+5.3%) | $68.00M(+23.4%) |
Jun 2017 | - | $20.90M(+34.0%) | $55.10M(+23.5%) |
Mar 2017 | - | $15.60M(+64.2%) | $44.60M(+17.4%) |
Dec 2016 | $38.00M(-23.7%) | $9.50M(+4.4%) | $38.00M(-36.7%) |
Sep 2016 | - | $9.10M(-12.5%) | $60.00M(-2.3%) |
Jun 2016 | - | $10.40M(+15.6%) | $61.40M(+12.0%) |
Mar 2016 | - | $9.00M(-71.4%) | $54.80M(+10.0%) |
Dec 2015 | $49.80M(+5.1%) | $31.50M(+200.0%) | $49.80M(+142.4%) |
Sep 2015 | - | $10.50M(+176.3%) | $20.54M(-13.3%) |
Jun 2015 | - | $3.80M(-5.0%) | $23.69M(-27.6%) |
Mar 2015 | - | $4.00M(+78.3%) | $32.72M(-31.0%) |
Dec 2014 | $47.40M(+48.5%) | $2.24M(-83.6%) | $47.40M(-19.1%) |
Sep 2014 | - | $13.64M(+6.3%) | $58.57M(+7.8%) |
Jun 2014 | - | $12.84M(-31.3%) | $54.34M(+17.3%) |
Mar 2014 | - | $18.68M(+39.2%) | $46.34M(+45.2%) |
Dec 2013 | $31.91M(-71.5%) | $13.41M(+42.4%) | $31.91M(-19.7%) |
Sep 2013 | - | $9.42M(+94.7%) | $39.75M(+7.2%) |
Jun 2013 | - | $4.84M(+14.0%) | $37.06M(-51.1%) |
Mar 2013 | - | $4.24M(-80.0%) | $75.87M(-32.2%) |
Dec 2012 | $111.91M(+211.0%) | $21.25M(+215.8%) | $111.91M(+24.5%) |
Sep 2012 | - | $6.73M(-84.6%) | $89.90M(-11.0%) |
Jun 2012 | - | $43.64M(+8.3%) | $101.02M(+44.5%) |
Mar 2012 | - | $40.28M(-5492.5%) | $69.92M(+94.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $35.98M(+93.0%) | -$747.00K(-104.2%) | $35.98M(-14.7%) |
Sep 2011 | - | $17.84M(+42.2%) | $42.17M(+48.4%) |
Jun 2011 | - | $12.55M(+98.0%) | $28.41M(+52.6%) |
Mar 2011 | - | $6.34M(+16.4%) | $18.61M(-0.1%) |
Dec 2010 | $18.64M(-80.5%) | $5.44M(+33.3%) | $18.64M(-46.3%) |
Sep 2010 | - | $4.08M(+48.2%) | $34.71M(-36.5%) |
Jun 2010 | - | $2.75M(-56.7%) | $54.68M(-32.1%) |
Mar 2010 | - | $6.36M(-70.4%) | $80.49M(-15.6%) |
Dec 2009 | $95.40M(-23.3%) | $21.51M(-10.6%) | $95.40M(-13.6%) |
Sep 2009 | - | $24.06M(-15.8%) | $110.45M(-13.3%) |
Jun 2009 | - | $28.57M(+34.3%) | $127.35M(-3.9%) |
Mar 2009 | - | $21.27M(-41.8%) | $132.49M(+6.5%) |
Dec 2008 | $124.42M(+221.8%) | $36.56M(-10.7%) | $124.42M(+17.0%) |
Sep 2008 | - | $40.95M(+21.5%) | $106.37M(+46.3%) |
Jun 2008 | - | $33.71M(+155.5%) | $72.72M(+66.0%) |
Mar 2008 | - | $13.19M(-28.7%) | $43.81M(+13.3%) |
Dec 2007 | $38.66M(+147.3%) | $18.51M(+153.5%) | $38.66M(+70.1%) |
Sep 2007 | - | $7.30M(+52.1%) | $22.72M(+16.4%) |
Jun 2007 | - | $4.80M(-40.3%) | $19.52M(-13.5%) |
Mar 2007 | - | $8.04M(+212.2%) | $22.57M(+44.4%) |
Dec 2006 | $15.63M(+155.6%) | $2.58M(-37.1%) | $15.63M(+4.1%) |
Sep 2006 | - | $4.10M(-47.8%) | $15.02M(+31.4%) |
Jun 2006 | - | $7.85M(+609.4%) | $11.43M(+68.5%) |
Mar 2006 | - | $1.11M(-43.4%) | $6.78M(+10.9%) |
Dec 2005 | $6.12M(+17.3%) | $1.96M(+283.7%) | $6.12M(+20.4%) |
Sep 2005 | - | $510.00K(-84.1%) | $5.08M(-2.3%) |
Jun 2005 | - | $3.21M(+627.7%) | $5.20M(+0.2%) |
Mar 2005 | - | $441.00K(-52.2%) | $5.19M(-0.4%) |
Dec 2004 | $5.22M(-25.5%) | $922.00K(+45.9%) | $5.22M(-38.7%) |
Sep 2004 | - | $632.00K(-80.2%) | $8.51M(+0.7%) |
Jun 2004 | - | $3.20M(+589.4%) | $8.44M(+31.8%) |
Mar 2004 | - | $464.00K(-89.0%) | $6.41M(-8.5%) |
Dec 2003 | $7.00M(+95.6%) | $4.21M(+638.8%) | $7.00M(+87.8%) |
Sep 2003 | - | $570.00K(-50.9%) | $3.73M(-27.8%) |
Jun 2003 | - | $1.16M(+9.5%) | $5.17M(+23.9%) |
Mar 2003 | - | $1.06M(+13.2%) | $4.17M(+16.4%) |
Dec 2002 | $3.58M(+421.3%) | $937.00K(-53.3%) | $3.58M(+23.7%) |
Sep 2002 | - | $2.01M(+1123.8%) | $2.90M(+191.5%) |
Jun 2002 | - | $164.00K(-65.3%) | $993.30K(+2.7%) |
Mar 2002 | - | $473.00K(+88.1%) | $966.90K(+40.7%) |
Dec 2001 | $687.00K(+7.4%) | $251.40K(+139.7%) | $687.00K(-3.6%) |
Sep 2001 | - | $104.90K(-23.8%) | $712.60K(+2.4%) |
Jun 2001 | - | $137.60K(-28.7%) | $695.90K(+3.0%) |
Mar 2001 | - | $193.10K(-30.3%) | $675.60K(+5.6%) |
Dec 2000 | $639.90K(-72.2%) | $277.00K(+214.1%) | $639.90K(-16.1%) |
Sep 2000 | - | $88.20K(-24.8%) | $762.90K(-66.5%) |
Jun 2000 | - | $117.30K(-25.5%) | $2.27M(-3.5%) |
Mar 2000 | - | $157.40K(-60.7%) | $2.36M(+2.5%) |
Dec 1999 | $2.30M(+130.0%) | $400.00K(-75.0%) | $2.30M(+21.1%) |
Sep 1999 | - | $1.60M(+700.0%) | $1.90M(+533.3%) |
Jun 1999 | - | $200.00K(+100.0%) | $300.00K(+200.0%) |
Mar 1999 | - | $100.00K | $100.00K |
Dec 1998 | $1.00M | - | - |
FAQ
- What is United Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for United Therapeutics?
- What is United Therapeutics annual CAPEX year-on-year change?
- What is United Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for United Therapeutics?
- What is United Therapeutics quarterly CAPEX year-on-year change?
- What is United Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for United Therapeutics?
- What is United Therapeutics TTM CAPEX year-on-year change?
What is United Therapeutics annual capital expenditures?
The current annual CAPEX of UTHR is $246.50M
What is the all time high annual CAPEX for United Therapeutics?
United Therapeutics all-time high annual capital expenditures is $246.50M
What is United Therapeutics annual CAPEX year-on-year change?
Over the past year, UTHR annual capital expenditures has changed by +$16.10M (+6.99%)
What is United Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of UTHR is $74.90M
What is the all time high quarterly CAPEX for United Therapeutics?
United Therapeutics all-time high quarterly capital expenditures is $86.70M
What is United Therapeutics quarterly CAPEX year-on-year change?
Over the past year, UTHR quarterly capital expenditures has changed by +$36.70M (+96.07%)
What is United Therapeutics TTM capital expenditures?
The current TTM CAPEX of UTHR is $283.20M
What is the all time high TTM CAPEX for United Therapeutics?
United Therapeutics all-time high TTM capital expenditures is $283.20M
What is United Therapeutics TTM CAPEX year-on-year change?
Over the past year, UTHR TTM capital expenditures has changed by +$55.90M (+24.59%)